FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wilma Bergman

Research Profile

Disorders

Genes & Molecular Sequences

Genes, p16

Concepts & Ideas

Geographic Areas

Netherlands

Physiology

Chemicals & Drugs

Cyclin-Dependent Kinase Inhibitor p16

Anatomy

Procedures

Dermoscopy

Phenomena

Sunlight

Co-author Network

Publications

TOP 3
Koen D Quint; Jeanet A C ter Huurne; Jasper I van der Rhee; Nienke van der Stoep; Ron Wolterbeek; Wilma Bergman; Nelleke A Gruis; Nicole A Kukutsch
Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Giuseppe Argenziano; Renato Marchiori Bakos; Wilma Bergman; Andreas Blum; Paolo Broganelli; Horacio Cabo; Filomena Caltagirone; Caterina Catricalà; Maurizio Coppini; Lucas Dewes; Maria Grazia Francia; Alessandro Garrone; Giovanni Ghigliotti; Jason Giacomel; Jean-Yves Gourhant; Gerald Hlavin; Rainer Hofmann-Wellenhof; Nicole A Kukutsch; Dario Lipari; Gennaro Melchionda; Fezal Ozdemir; giovanni pellacani; Riccardo Pellicano; Susana Puig; Massimiliano Scalvenzi; Ana Maria Sortino-Rachou; Bengu Gerceker Turk; Anna Rosa Virgili; Iris Zalaudek; Harald Kittler
Total body skin examination for skin cancer screening in patients with focused symptoms.
Linda Gao; Wilma Bergman; Femke A De Snoo; Paul J Hensbergen; Jacoba J Out-Luiting; Remco van Doorn; Frans van Nieuwpoort; Nelleke A Gruis
Genome-wide analysis of gene and protein expression of dysplastic naevus cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wilma Bergman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Koen D Quint; Jeanet A C ter Huurne; Jasper I van der Rhee; Nienke van der Stoep; Ron Wolterbeek; Wilma Bergman; Nelleke A Gruis; Nicole A Kukutsch
Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Acta dermato-venereologica 2012;92(6):587-92.
2012: Giuseppe Argenziano; Renato Marchiori Bakos; Wilma Bergman; Andreas Blum; Paolo Broganelli; Horacio Cabo; Filomena Caltagirone; Caterina Catricalà; Maurizio Coppini; Lucas Dewes; Maria Grazia Francia; Alessandro Garrone; Giovanni Ghigliotti; Jason Giacomel; Jean-Yves Gourhant; Gerald Hlavin; Rainer Hofmann-Wellenhof; Nicole A Kukutsch; Dario Lipari; Gennaro Melchionda; Fezal Ozdemir; giovanni pellacani; Riccardo Pellicano; Susana Puig; Massimiliano Scalvenzi; Ana Maria Sortino-Rachou; Bengu Gerceker Turk; Anna Rosa Virgili; Iris Zalaudek; Harald Kittler
Total body skin examination for skin cancer screening in patients with focused symptoms.
Journal of the American Academy of Dermatology 2012;66(2):212-9.
2012: Linda Gao; Wilma Bergman; Femke A De Snoo; Paul J Hensbergen; Jacoba J Out-Luiting; Remco van Doorn; Frans van Nieuwpoort; Nelleke A Gruis
Genome-wide analysis of gene and protein expression of dysplastic naevus cells.
Journal of skin cancer 2012;2012():981308.
2011: Jasper I van der Rhee; Hans F A Vasen; Femke A De Snoo; Nelleke A Gruis; Pieta Krijnen; Nicole A Kukutsch; Hein Putter; Wilma Bergman
Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
Journal of the American Academy of Dermatology 2011;65(2):281-8.
2011: Jasper I van der Rhee; Hans F A Vasen; Femke A De Snoo; Nelleke A Gruis; Nicole A Kukutsch; Wolter J Mooi; Hein Putter; Wilma Bergman
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
Journal of the American Academy of Dermatology 2011;65(2):289-96.
2011: Jasper I van der Rhee; Wilma Bergman; Nicole A Kukutsch
Impact of dermoscopy on the management of high-risk patients from melanoma families: a prospective study.
Acta dermato-venereologica 2011;91(4):428-31.
2011: Hans F A Vasen; Martin Wasser; Anneke van Mil; RA Tollenaar; Marja Konstantinovski; Nelleke A Gruis; Wilma Bergman; Frederik J Hes; Daniel W Hommes; G Johan A Offerhaus; Hans Morreau; BA Bonsing; Wouter H de Vos tot Nederveen Cappel
Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Gastroenterology 2011;140(3):850-6.
2010: J I van der Rhee; Wilma Bergman; N A Kukutsch
The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study.
The British journal of dermatology 2010;162(3):563-7.
2010: Koen D Quint; Annette H M Van Der Helm-Van Mil; Wilma Bergman; A P M Lavrijsen
[Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis].
Nederlands tijdschrift voor geneeskunde 2010;154():A1614.
2008: Femke A De Snoo; D Timothy Bishop; Wilma Bergman; Inge van Leeuwen; Clasine van der Drift; Frans A van Nieuwpoort; Coby J Out-Luiting; H F A Vasen; Jeanet A C ter Huurne; Rune R Frants; Rein Willemze; Martijn H Breuning; Nelleke A Gruis
Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7151-7.
2008: Femke A De Snoo; Jouke-Jan Hottenga; Elizabeth M Gillanders; Lodewijk A Sandkuijl; Mary Pat Jones; Wilma Bergman; Clasine van der Drift; Inge van Leeuwen; Lenny van Mourik; Jeanet A C Ter Huurne; Rune R Frants; Rein Willemze; Martijn H Breuning; Jeffrey M. Trent; Nelleke A Gruis
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
European journal of human genetics : EJHG 2008;16(9):1135-41.
2008: Femke A De Snoo; Samantha R Riedijk; Anneke M van Mil; Wilma Bergman; Jeanet A C ter Huurne; Reinier Timman; Wieke Bertina; Nelleke A Gruis; H F A Vasen; Arie van Haeringen; Martijn H Breuning; Aad Tibben
Genetic testing in familial melanoma: uptake and implications.
Psycho-oncology 2008;17(8):790-6.
2008: Mark Harland; Alisa M Goldstein; Kairen Kukalizch; Claire Taylor; David Hogg; Susana Puig; Celia Badenas; Nelleke Gruis; Jeanet ter Huurne; Wilma Bergman; Nicholas K Hayward; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Maria Teresa Landi; Giovanna Bianchi Scarra; Paola Ghiorzo; Peter Kanetsky; David E Elder; Graham J Mann; Elizabeth A Holland; D Timothy Bishop; Julia Newton Bishop
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).
European journal of cancer (Oxford, England : 1990) 2008;44(9):1269-74.
2007: E R Koomen; A Joosse; Ron Herings; Mariel Casparie; Wilma Bergman; T Nijsten; Henk-Jan Guchelaar
Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?
European journal of cancer (Oxford, England : 1990) 2007;43(17):2580-9.
2007: Femke A De Snoo; Marije W Kroon; Wilma Bergman; Jeanet A C ter Huurne; Jeanine J Houwing-Duistermaat; Leny van Mourik; Dyon G C T M Snels; Martijn H Breuning; Rein Willemze; Rune R Frants; Nelleke A Gruis
From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
Journal of the American Academy of Dermatology 2007;56(5):748-52.
2007: Wilma Bergman; Nelleke A Gruis
Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Archives of dermatology 2007;143(4):525-6.
2005: Samantha R Riedijk; Femke A De Snoo; Sandra van Dijk; Wilma Bergman; Arie van Haeringen; S Silberg; Thérèse van Elderen; Aad Tibben
Hereditary melanoma and predictive genetic testing: why not?
Psycho-oncology 2005;14(9):738-45.
2004: Michelle J Hayes; Anna Koundouris; Nelleke A Gruis; Wilma Bergman; Gordon G Peters; Alison J Sinclair
p16(INK4A)-independence of Epstein-Barr virus-induced cell proliferation and virus latency.
The Journal of general virology 2004;85(Pt 6):1381-6.
2003: Wouter H de Vos tot Nederveen Cappel; G Johan A Offerhaus; Marjo Van Puijenbroek; Eric Caspers; Nelleke A Gruis; Femke A De Snoo; Cornelis B H W Lamers; Gerrit Griffioen; Wilma Bergman; H F A Vasen; Hans Morreau
Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3598-605.
2003: Elizabeth M Gillanders; Suh-Hang Hank Juo; Elizabeth A Holland; MaryPat Jones; Derek Nancarrow; Diana Freas-Lutz; Raman Sood; Naeun Park; Mezbah U Faruque; Carol Markey; Richard F Kefford; Jane Palmer; Wilma Bergman; D Timothy Bishop; Margaret A Tucker; Brigitte Bressac De-Paillerets; Johan Hansson; Mitchell Stark; Nelleke A Gruis; Julia Newton Bishop; Alisa M Goldstein; Joan E Bailey-Wilson; Graham J Mann; Nicholas Hayward; Jeffrey M. Trent
Localization of a novel melanoma susceptibility locus to 1p22.
American journal of human genetics 2003;73(2):301-13.
2003: Stan Pavel; Nico P M Smit; Hans van der Meulen; Ria M Kolb; Anton J de Groot; Pieter A van der Velden; Nelleke A Gruis; Wilma Bergman
Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case.
Melanoma research 2003;13(2):171-8.
2003: Femke A De Snoo; Wilma Bergman; Nelleke A Gruis
Familial melanoma: a complex disorder leading to controversy on DNA testing.
Familial cancer 2003;2(2):109-16.
2002: Richard F Kefford; Julia Newton Bishop; Margaret Tucker; Brigitte Bressac De-Paillerets; Giovanna Bianchi-Scarrá; Wilma Bergman; Alisa Goldstein; Susana Puig; Rona Mackie; David E Elder; Johan Hansson; Nicholas Hayward; David Hogg; Håkan Olsson
Genetic testing for melanoma.
The lancet oncology 2002;3(11):653-4.
2002: D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac De-Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Journal of the National Cancer Institute 2002;94(12):894-903.
2002: Sharon Brookes; Janice Rowe; Margarida Ruas; Susana Llanos; Paula A Clark; Martine Lomax; Marion C James; Radost Vatcheva; Stewart Bates; Karen H Vousden; David Parry; Nelleke A Gruis; Nico P M Smit; Wilma Bergman; Gordon Peters
INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
The EMBO journal 2002;21(12):2936-45.
2001: Pieter A van der Velden; Lodewijk A Sandkuijl; Wilma Bergman; Stan Pavel; L van Mourik; Rune R Frants; Nelleke A Gruis
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.
American journal of human genetics 2001;69(4):774-9.
2001: C Kennedy; Jeanet A C ter Huurne; M Berkhout; Nelleke A Gruis; Maarten T Bastiaens; Wilma Bergman; Rein Willemze; Jan Nico Bouwes Bavinck
Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
The Journal of investigative dermatology 2001;117(2):294-300.
2001: Maarten T Bastiaens; Jeanet A C ter Huurne; Nelleke A Gruis; Wilma Bergman; Rudi G J Westendorp; Bert-Jan Vermeer; Jan N Bouwes Bavinck
The melanocortin-1-receptor gene is the major freckle gene.
Human molecular genetics 2001;10(16):1701-8.
2001: Pieter A van der Velden; J A W Metzelaar-Blok; Wilma Bergman; H Monique; H Monique H Hurks; Rune R Frants; Nelleke A Gruis; Martine J Jager
Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
Cancer research 2001;61(13):5303-6.
2001: J J Stam-Posthuma; C van Duinen; Erik Scheffer; J Vink; Wilma Bergman
Multiple primary melanomas.
Journal of the American Academy of Dermatology 2001;44(1):22-7.
2000: MM Hulshof; Jan N Bouwes Bavinck; Wilma Bergman; A A Masclee; L Heickendorff; F C Breedveld; B A Dijkmans
Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.
Journal of the American Academy of Dermatology 2000;43(6):1017-23.
2000: Nelleke A Gruis; Wilma Bergman
[From gene to disease; from p16 to melanoma].
Nederlands tijdschrift voor geneeskunde 2000;144(44):2100-2.
2000: H F A Vasen; Nelleke A Gruis; Rune R Frants; Pieter A van der Velden; Elysée Hille; Wilma Bergman
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
International journal of cancer. Journal international du cancer 2000;87(6):809-11.
2000: Michiel W van der Linden; Rudi G J Westendorp; Augueste Sturk; Wilma Bergman; Tom W J Huizinga
High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2000;48(5):327-34.
2000: Margreet Scharloo; Adrian A Kaptein; JA Weinman; Wilma Bergman; Bert-Jan Vermeer; Harry G M Rooijmans
Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up.
The British journal of dermatology 2000;142(5):899-907.
2000: I Ak; Marcel P M Stokkel; Wilma Bergman; Ernest K J Pauwels
Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment.
European journal of nuclear medicine 2000;27(4):447-58.
2000: Julia Newton-Bishop; M Bradburn; Wilma Bergman; A Osterlind; Elizabeth Pinney; Inger Rosdahl; L Scerri; Michael Weichenthal; D Mant; Eckard W Breitbart; P Karlsson; Douglas Altman
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study.
The British journal of dermatology 2000;142(2):331-7.
1999: Richard F Kefford; Julia Newton-Bishop; Wilma Bergman; M A Tucker
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3245-51.
1999: Nelleke A Gruis; Pieter A van der Velden; Wilma Bergman; Rune R Frants
Familial melanoma; CDKN2A and beyond.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1999;4(1):50-4.
1999: Pieter A van der Velden; Lodewijk A Sandkuijl; Wilma Bergman; Elysée Hille; Rune R Frants; Nelleke A Gruis
A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.
Genome research 1999;9(6):575-80.
1999: Dyon G C T M Snels; Elysée Hille; Nelleke A Gruis; Wilma Bergman
Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic.
Journal of the American Academy of Dermatology 1999;40(5 Pt 1):686-93.
1998: J J Stam-Posthuma; J Vink; S le Cessie; J A Bruijn; Wilma Bergman; Stan Pavel
Effect of topical tretinoin under occlusion on atypical naevi.
Melanoma research 1998;8(6):539-48.
1998: Nelleke A Gruis; Pieter A van der Velden; Wilma Bergman; Rune R Frants
Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
Bulletin du cancer 1998;85(7):627-30.
1998: Margreet Scharloo; Adrian A Kaptein; JA Weinman; J M Hazes; L N Willems; Wilma Bergman; Harry G M Rooijmans
Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis.
Journal of psychosomatic research 1998;44(5):573-85.
1998: Elysée Hille; Erik van Duijn; Nelleke A Gruis; F R Rosendaal; Wilma Bergman; Jan P Vandenbroucke
Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.
The Journal of investigative dermatology 1998;110(5):788-92.
1998: CL Van Hees; Martine J Jager; JC Bleeker; HM Kemme; Wilma Bergman
Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives.
Melanoma research 1998;8(2):175-80.
1998: MM Hulshof; Arie van Haeringen; Nelleke A Gruis; D C Snels; Wilma Bergman
Multiple agminate Spitz naevi.
Melanoma research 1998;8(2):156-60.
1997: Julia Newton-Bishop; M Collins; B R Hughes; Douglas Altman; Wilma Bergman; Eckard W Breitbart; B de Stavola; H Elvers; F Gylling; M Koopman; R Marks; M Martin; M Martin; G Murphy; A Osterlind; N Wetton
What do children aged 5 to 11 years old know about the sun and skin cancer? The practical difficulties of international collaborative research when analysis of language is involved.
Melanoma research 1997;7(5):428-35.
1997: M B Crijns; C Klaver; A de Boer; CL Van Hees; Bert-Jan Vermeer; J Vandenbroucke; Wilma Bergman
Ultraviolet exposure and the development of banal and atypical naevi--a cross-sectional study on Curaçao and in The Netherlands.
Melanoma research 1997;7(5):407-16.
1996: Jan N Bouwes Bavinck; M Crijns; Bert-Jan Vermeer; F J van der Woude; Frans H J Claas; Herbert Pfister; A Green; Wilma Bergman
Chronic sun exposure and age are inversely associated with nevi in adult renal transplant recipients.
The Journal of investigative dermatology 1996;106(5):1036-41.
1995: Nelleke A Gruis; Pieter A van der Velden; Lodewijk A Sandkuijl; D E Prins; J Weaver-Feldhaus; Alexander Kamb; Wilma Bergman; Rune R Frants
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
Nature genetics 1995;10(3):351-3.
1995: Nelleke A Gruis; Lodewijk A Sandkuijl; Pieter A van der Velden; Wilma Bergman; Rune R Frants
CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.
Melanoma research 1995;5(3):169-77.
1995: M B Crijns; C C Klaver; A de Boer; C L Van Hees; Bert-Jan Vermeer; J P Vandenbroucke; Wilma Bergman
A comparative study of atypical and melanocytic naevi on the tropical island Curaçao and in The Netherlands.
Melanoma research 1995;5(3):161-7.
1994: Wilma Bergman; Nelleke A Gruis; Lodewijk A Sandkuijl; R R Frants
Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.
The Journal of investigative dermatology 1994;103(5 Suppl):122S-125S.
1994: R L van Leeuwen; J Vink; Wilma Bergman; M Herfst; J A Bruijn
Agminate-type combined nevus consisting of a common blue nevus with a junctional Spitz nevus.
Archives of dermatology 1994;130(8):1074-5.
1994: C L van Hees; A de Boer; Martine J Jager; JC Bleeker; H M Kakebeeke; M B Crijns; J P Vandenbroucke; Wilma Bergman
Are atypical nevi a risk factor for uveal melanoma? A case-control study.
The Journal of investigative dermatology 1994;103(2):202-5.
1994: K C Noz; L Roza; Wilma Bergman; F Darroudi; AA Schothorst
UV induction of cyclobutane thymine dimers in the DNA of cultured melanocytes from foreskin, common melanocytic nevi and dysplastic nevi.
Photochemistry and photobiology 1994;59(5):534-40.
1993: Nelleke A Gruis; Lodewijk A Sandkuijl; J L Weber; A van der Zee; Anne-Marijke Borgstein; Wilma Bergman; Rune R Frants
Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count.
Melanoma research 1993;3(4):271-7.
1993: M B Crijns; Wilma Bergman; M J Berger; J Hermans; A J Sober
On naevi and melanomas in dysplastic naevus syndrome patients.
Clinical and experimental dermatology 1993;18(3):248-52.
1993: MC Van Praag; Jan Nico Bouwes Bavinck; Wilma Bergman; F R Rosendaal; A Mieke Mommaas; I Bruynzeel; E Scheffer; Bert-Jan Vermeer; J A Bruijn
PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
Journal of the American Academy of Dermatology 1993;28(3):412-7.
1992: E Kuppens; Wilma Bergman; K Welvaart; Jan A Bruijn; E Scheffer
Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy.
Melanoma research 1992;2(1):71-4.
1992: Wilma Bergman; Nelleke A Gruis; R R Frants
The Dutch FAMMM family material: clinical and genetic data.
Cytogenetics and cell genetics 1992;59(2-3):161-4.
1992: Wilma Bergman; R M Fusaro
Precursor lesions to melanoma.
Clinics in dermatology 1992;10(1):21-9.
1991: M B Crijns; J Vink; C L Van Hees; Wilma Bergman; Bert-Jan Vermeer
Dysplastic nevi. Occurrence in first- and second-degree relatives of patients with 'sporadic' dysplastic nevus syndrome.
Archives of dermatology 1991;127(9):1346-51.
1991: I Bruynzeel; Wilma Bergman; H M Hartevelt; C C Kenter; E A Van de Velde; AA Schothorst; D Suurmond
'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
The British journal of dermatology 1991;124(1):49-55.
1990: J Vink; M B Crijns; C M Mooy; Wilma Bergman; J A Oosterhuis; L N Went
Ocular melanoma in families with dysplastic nevus syndrome.
Journal of the American Academy of Dermatology 1990;23(5 Pt 1):858-62.
1990: MC Van Praag; J G van der Schroeff; Wilma Bergman; A Mieke Mommaas
[Tretinoin; promise for eternal cutaneous youth?].
Nederlands tijdschrift voor geneeskunde 1990;134(25):1232-3.
1990: Nelleke A Gruis; Wilma Bergman; R R Frants
Locus for susceptibility to melanoma on chromosome lp.
The New England journal of medicine 1990;322(12):853-4.
1989: Arie van Haeringen; Wilma Bergman; M R Nelen; E van der Kooij-Meijs; I Hendrikse; Juul Wijnen; PM Khan; E C Klasen; Rune R Frants
Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families.
Genomics 1989;5(1):61-4.
1989: H F A Vasen; Wilma Bergman; Arie van Haeringen; E Scheffer; E A van Slooten
The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands.
European journal of cancer & clinical oncology 1989;25(2):337-41.
1988: Wilma Bergman; D J Ruiter; E Scheffer; Willem A van Vloten
Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.
Cancer 1988;61(8):1660-6.
1988: P M Steijlen; Wilma Bergman; J Hermans; E Scheffer; Willem A van Vloten; D J Ruiter
The efficacy of histopathological criteria required for diagnosing dysplastic naevi.
Histopathology 1988;12(3):289-300.
1987: Wilma Bergman; A Palan; Arie van Haeringen; I van Leeuwen-Cornelisse; L N Went
[Familial dysplastic nevus syndrome in the Netherlands; various clinical and genetic aspects].
Nederlands tijdschrift voor geneeskunde 1987;131(23):994-6.
1987: D Suurmond; Wilma Bergman
[Melanoma or no melanoma? Various practical guidelines for the differential clinical diagnosis of pigmented skin tumors].
Nederlands tijdschrift voor geneeskunde 1987;131(23):981-5.
1986: Wilma Bergman; A Palan; L N Went
Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome.
Annals of human genetics 1986;50(Pt 3):249-58.
1984: D J Ruiter; Wilma Bergman; K Welvaart; E Scheffer; W A van Vloten; C Russo; S Ferrone
Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
Cancer research 1984;44(9):3930-5.